Clinical Trials Directory

Trials / Unknown

UnknownNCT04388735

Multiple Myeloma (MM) Quality of Life (QOL) Study

Quality of Life and Psychological Distress in Patients With Multiple Myeloma and Their Caregivers

Status
Unknown
Phase
Study type
Observational
Enrollment
360 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The main purpose of this study is to examine differences in quality of life and psychological distress for both Multiple Myeloma patients receiving treatment and their caregivers and to assess patient and caregiver prognostic understanding (understanding of the likely course of a disease over time) of Multiple Myeloma to guide development of more personalized treatment plans. This study looks to further understand quality of life changes throughout multiple myeloma therapy for both patients and caregivers to help determine ways to improve patient and caregiver understanding of illness and in turn, tailor customized treatment that best aligns with patient preferences. The study will use a series of questionnaires to measure quality of life, mood, coping strategies, and prognostic understanding.

Detailed description

This research study's procedures include screening for eligibility, participant designation of a caregiver and a series of questionnaires. \- It is expected that about 180 people undergoing treatment for multiple myeloma and up to 180 of their caregivers will take part in this research study. \-- The questionnaires are completed one time only and measure quality of life, mood, coping strategies, and prognostic understanding and can be completed in the hospital, clinic, over the email, or telephone with assistance provided as needed.Questionnaires take approximately 20 minutes to complete.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnaireSeries of questions covering quality of life, physical and psychological symptom burden, mood, and illness and prognostic understanding administered in person or remotely.

Timeline

Start date
2020-06-01
Primary completion
2021-11-15
Completion
2022-05-16
First posted
2020-05-14
Last updated
2020-05-14

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04388735. Inclusion in this directory is not an endorsement.